Stem cell treatment to prevent bile duct problems after liver transplant
Part of Digestive system clinical trials.
This study tests whether a type of stem cell, given during liver transplant surgery, can help prevent bile duct complications. It is for people receiving a liver from a living donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on the list for a liver transplant.
- Your liver transplant will be from a living donor, not a deceased donor.
- You do not have an uncontrolled infection.
- Your body mass index (BMI) is 40 or less.
- You are not pregnant or breastfeeding.
- You have not used an investigational drug or device in the past 60 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special temporary stent that breaks down over time to help open a narrowed bile duct after a liver transplant. It may help avoid long-term plastic stents or additional surgery.
This trial tests placing a temporary drainage stent during liver transplant surgery in children to see if it helps prevent bile duct complications. It might improve recovery for young transplant recipients.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This study tests whether a special type of stem cell therapy (called mesenchymal stem cells) can help people with a severe liver condition called acute-on-chronic liver failure (ACLF). The goal is to see if this treatment can improve liver function and reduce the need for a liver transplant.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
This trial tests whether using amniotic tissue during bile duct connection surgery can improve outcomes for people receiving a liver transplant from a living donor.
Hear when a new Liver Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.